No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PGNY Progyny
- 28.950
- +0.770+2.73%
Close Jul 12 16:00 ET
- 29.000
- +0.050+0.17%
Post 18:13 ET
2.76BMarket Cap47.46P/E (TTM)
28.980High28.295Low618.55KVolume28.440Open28.180Pre Close17.80MTurnover0.75%Turnover Ratio46.69P/E (Static)95.22MShares44.95052wk High4.82P/B2.39BFloat Cap23.90052wk Low--Dividend TTM82.46MShs Float68.320Historical High--Div YieldTTM2.43%Amplitude13.290Historical Low28.779Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Pinnacle Egg Bank Relaunches With New Pricing, Expanded Inventory, and Enhanced Donor Profiles
Pinnacle Egg Bank Makes it Easier for Parents-to-Be to Find their Perfect Egg Donor MatchPHOENIX, July 11, 2024 /PRNewswire/ -- Pinnacle Egg Bank is thrilled to announce its relaunch, featuring new
Progyny(PGNY.US) Director Sells US$41,506.18 in Common Stock
$Progyny(PGNY.US)$ Director Scott Cheryl sold 1,462 shares of common stock on Jun 28, 2024 at an average price of $28.39 for a total value of $41,506.18.Source: Announcement What is statement of chang
Progyny, Inc. to Host 2024 Inaugural Investor Day
NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that it will host its inaugural Investor Day
J.P. Morgan Maintains Progyny(PGNY.US) With Buy Rating
J.P. Morgan analyst Anne Samuel maintains $Progyny(PGNY.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 44.4% and a total average return of 11.5% over the past yea
Progyny Acquires Berlin-based Apryl
Express News | Progyny Reports Acquisition Of Berlin-Based Fertility Benefits Platform Apryl; No Terms Disclosed
Comments
Progyny's CEO, Pete Anevski, is thrilled about the executive team expansion, confident that the new members' expertise will boost the company's growth in fertility, family building, and women's health benefits. Both Higgins and Leist are excited to contribute to Progyny's growth and innovation.
Press Release: Progyny Expands Its Leadership TeamInvestors may be justifying Progyny's high P/E ratio by betting on its potential to outperform market growth. The company's strong forecast growth is believed to be upholding its high P/E and providing strong support to its share price.
Progyny, with a low ROCE score of 9.2%, underscores promising fundamentals following its foray into profitability. Having offered a notable 27% to shareholders over three years, its developing factors necessitate a deeper analysis for future investment opportunities.
$Progyny(PGNY.US$ Bought in at 64.40 and now what do I do sigh
6
3
$Costco(COST.US$ Costco (COST) target raised by Citigroup from $460 to $495 at Neutral. Stock currently around $448
$Etsy Inc(ETSY.US$ Etsy (ETSY) target raised by Loop Capital from $220 to $245 at Buy. Stock currently around $211
$Generac(GNRC.US$ Generac (GNRC) target raised by Roth Capital from $480 to $500 at Buy. Stock currently around $425
$Fortinet(FTNT.US$ Fortinet (FTNT) target raised by Cowen from $335 to $385 at Outperform. Stock currently around $288
$NVIDIA(NVDA.US$ NVIDIA (NVDA) target raised by Susquehanna from $220 to $250 at Positive. Stock currently around $206
$Progyny(PGNY.US$ Progyny (PGNY) target raiosed by Barclays from $72 to $80 at Overweight. Stock currently around $56
$Etsy Inc(ETSY.US$ Etsy (ETSY) target raised by Loop Capital from $220 to $245 at Buy. Stock currently around $211
$Generac(GNRC.US$ Generac (GNRC) target raised by Roth Capital from $480 to $500 at Buy. Stock currently around $425
$Fortinet(FTNT.US$ Fortinet (FTNT) target raised by Cowen from $335 to $385 at Outperform. Stock currently around $288
$NVIDIA(NVDA.US$ NVIDIA (NVDA) target raised by Susquehanna from $220 to $250 at Positive. Stock currently around $206
$Progyny(PGNY.US$ Progyny (PGNY) target raiosed by Barclays from $72 to $80 at Overweight. Stock currently around $56
3
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg